Development of software for calculating the results of medicinal substances bioequivalence

Author:

Shalaginova N V,Mikhlyakova E A,Gribkov D N,Mikhailina A V,Lebedeva E V

Abstract

Abstract International organizations have adopted and recognized drug standards, which should be guided by developers in the field of pharmacology. In practice, there is a problem: how to determine whether a reproduced drug sample really satisfies the world standard for its pharmacological action. It is required to implement an algorithm for checking and confirming the bioequivalence of drugs. The purpose of the study is to automate the verification of standards using an appropriate algorithm, i.e. to develop an application for calculating the results of medicinal substances bioequivalence. The methodology is based on the assumption that the identity in the sense of the created effect of the pharmacokinetic curves of the drug concentration in the blood versus time for the test drug and the standard means their therapeutic equivalence. Research methods include Python programming, use of libraries for data visualization; Visual Studio is an application development environment. The desired algorithm and requirements for the developed application are formulated in the results of the study, based on the study of theoretical issues of determining the medicinal substances bioequivalence. Finally, conclusions about the efficiency of the software are made and options for its improvement are proposed.

Publisher

IOP Publishing

Subject

General Physics and Astronomy

Reference11 articles.

1. Methods to control the empirical type I error rate in average bioequivalence tests for highly variable drugs;Deng;Statist. Meth. in Medical Research.,2020

2. Maximum type I error rate inflation from sample size reassessment when investigators are blind to treatment labels;Żebrowska;Statistics in Medicine,2015

3. Estimation after blinded sample size reassessment;Posch;Statist. Meth. in Medical Research,2016

4. Assessing the impact of cystic fibrosis on the antipyretic response of ibuprofen in children: Physiologically-based modeling as a candle in the dark;Cicali;British J. of Clinical Pharmac,2020

5. Simultaneous determination of amlodipine, losartan, and the losartan carboxylic acid active metabolite in human plasma by lc-ms/ms;Nai;Intern. J. of Pharmac. Research,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3